The U.S. Attorney’s office charged the companies with violating federal anti-kickback statutes in 2007. The companies avoided prosecution by agreeing to strict compliance procedures and federal monitoring.
Zimmer, Depuy, Biomet and Smith & Nephew remain subject to the terms of separate agreements entered into with the Office of Inspector General of the Department of Health and Human Services until 2012.
Read the Star-Ledger‘s report on the end of federal oversight for orthopedic device companies.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
